Intriguingly, while there are limited genetic perturbations in FP-RMS, it appears that the PAX3/7-FOXO1 fusion protein alters the ability of MRFs to activate a myogenic program, thus facilitating tumor proliferation. The gene discussed is PAX3; the disease is neoplasm.